Skip to content

Candesartan Cilexetil + Tizanidine Hydrochloride

Major 1 published source

This interaction is documented in this data source.

Candesartan Cilexetil
Checked as Candesartan
Tizanidine Hydrochloride
Checked as Tizanidine

What is documented

  1. Synergy

    Major

    via Candesartan and Tizanidine

    What happens

    Tizanidine may potentiate the hypotensive effect of some medications secondary to its alpha-2 adrenergic activity.

    What to do

    A lower initial dosage and cautious dosage titration should be considered when tizanidine is initiated in patients receiving hypotensive medications. Although single doses of less than 8 mg of tizanidine have not been shown effective for spasticity in controlled clinical studies, it may be prudent to initiate treatment with 4 mg doses and gradually increase in 2 to 4 mg increments until optimum effect is achieved. The dose can be repeated at 6 to 8 hour intervals as needed, up to a maximum of three doses in 24 hours and a total daily dosage of 36 mg. However, experience with single doses exceeding 8 mg and daily doses exceeding 24 mg is limited. Close monitoring for development of hypotension is recommended. Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.

    1 source

    1. "Product Information. Zanaflex (tizanidine)." Acorda Therapeutics (2001):

Keep checking